Early Identification, Accurate Diagnosis, and Treatment of Silicosis.
Journal
Canadian respiratory journal
ISSN: 1916-7245
Titre abrégé: Can Respir J
Pays: Egypt
ID NLM: 9433332
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
02
2022
revised:
05
04
2022
accepted:
15
04
2022
entrez:
5
5
2022
pubmed:
6
5
2022
medline:
7
5
2022
Statut:
epublish
Résumé
Silicosis is a global problem, and it has brought about great burdens to society and patients' families. The etiology of silicosis is clear, preventable, and controllable, but the onset is hidden and the duration is long. Thus, it is difficult to diagnose it early and treat it effectively, leaving workers unaware of the consequences of dust exposure. As such, a lack of details in the work history and a slow progression of lung disease contribute to the deterioration of patients until silicosis has advanced to fibrosis. These issues are the key factors impeding the diagnosis and the treatment of silicosis. This article reviews the literature on the early identification, diagnosis, and treatment of silicosis as well as analyzes the difficulties in the diagnosis and the treatment of silicosis and discusses its direction of future development.
Identifiants
pubmed: 35509892
doi: 10.1155/2022/3769134
pmc: PMC9061058
doi:
Substances chimiques
Dust
0
Silicon Dioxide
7631-86-9
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3769134Informations de copyright
Copyright © 2022 Tian Li et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Front Med (Lausanne). 2020 Dec 16;7:611728
pubmed: 33392232
Eur Respir Rev. 2020 Jul 3;29(156):
pubmed: 32620586
Lancet Respir Med. 2019 Aug;7(8):649-650
pubmed: 31109828
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30006-30008
pubmed: 33188085
Insights Imaging. 2021 Mar 10;12(1):33
pubmed: 33689008
Respirology. 2021 May;26(5):501-503
pubmed: 33626187
Theranostics. 2021 Jan 1;11(5):2381-2394
pubmed: 33500731
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Mol Ther Nucleic Acids. 2020 Jun 5;20:851-865
pubmed: 32464548
Chest. 2012 Mar;141(3):831
pubmed: 22396576
Toxicol Appl Pharmacol. 2018 Jun 1;348:117-122
pubmed: 29680408
Stem Cell Rev Rep. 2021 Apr;17(2):440-458
pubmed: 33211245
Int J Occup Med Environ Health. 2021 Aug 5;34(4):527-540
pubmed: 33658723
Free Radic Biol Med. 2008 Apr 1;44(7):1246-58
pubmed: 18226603
Environ Health Perspect. 2000 Aug;108 Suppl 4:675-84
pubmed: 10931786
Evid Based Complement Alternat Med. 2021 Nov 18;2021:4354054
pubmed: 34840587
Int J Mol Sci. 2020 Feb 11;21(4):
pubmed: 32054021
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9035-40
pubmed: 18577586
Biomed Pharmacother. 2020 May;125:109980
pubmed: 32028236
Chest. 2020 Sep;158(3):1060-1068
pubmed: 32563682
Part Fibre Toxicol. 2016 Sep 20;13(1):51
pubmed: 27650313
BMJ Case Rep. 2019 Dec 11;12(12):
pubmed: 31831514
Int J Environ Res Public Health. 2021 Aug 28;18(17):
pubmed: 34501684
J Comput Assist Tomogr. 2021 Sep-Oct 01;45(5):765-775
pubmed: 34347714
Physiol Res. 2021 Dec 31;70(S3):S275-S287
pubmed: 35099247
Int J Mol Sci. 2021 Apr 17;22(8):
pubmed: 33920534
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):27836-27846
pubmed: 33097669
Chest. 2021 Dec;160(6):2011-2014
pubmed: 34872666
Part Fibre Toxicol. 2014 Nov 19;11:58
pubmed: 25406505
Biomed Mater Eng. 2014;24(6):3389-95
pubmed: 25227049
Exp Ther Med. 2020 Mar;19(3):2195-2201
pubmed: 32104284
Toxicol Appl Pharmacol. 2018 Jul 1;350:1-10
pubmed: 29684394
Exp Ther Med. 2021 Jun;21(6):579
pubmed: 33850551
Lancet. 2012 May 26;379(9830):2008-18
pubmed: 22534002
J Occup Environ Med. 2021 Jul 1;63(7):e471-e473
pubmed: 34016915
Biomed Environ Sci. 2021 Jan 20;34(1):71-82
pubmed: 33531110
Chest. 2021 Dec;160(6):2007-2011
pubmed: 34872665
Int J Environ Res Public Health. 2021 Jul 31;18(15):
pubmed: 34360414
Front Pharmacol. 2021 Nov 22;12:739220
pubmed: 34880752
Cell Biosci. 2021 Feb 5;11(1):30
pubmed: 33546743
Am J Ind Med. 2017 Mar;60(3):248-254
pubmed: 28145560
Front Immunol. 2016 Mar 11;7:97
pubmed: 27014276
Exp Cell Res. 2019 Feb 15;375(2):1-9
pubmed: 30641040
J Inflamm Res. 2021 Apr 27;14:1647-1660
pubmed: 33948088
Clin Respir J. 2017 Mar;11(2):168-175
pubmed: 25919041
Cell Rep. 2017 Jan 31;18(5):1298-1311
pubmed: 28147282
PLoS One. 2012;7(7):e40301
pubmed: 22802960
Respirology. 2019 Dec;24(12):1220-1221
pubmed: 31407419
Exp Cell Res. 2019 Jul 15;380(2):131-140
pubmed: 31029634
Nat Commun. 2018 Dec 6;9(1):5226
pubmed: 30523277
J Pharmacol Exp Ther. 2014 May;349(2):209-20
pubmed: 24556663
Allergy. 2020 Nov;75(11):2805-2817
pubmed: 31989662
J Mol Med (Berl). 2021 Oct;99(10):1373-1384
pubmed: 34258628
J Med Imaging Radiat Oncol. 2020 Apr;64(2):229-235
pubmed: 32048474
Ind Health. 2019 Aug 3;57(4):495-502
pubmed: 30344228
Lancet Respir Med. 2019 Apr;7(4):283
pubmed: 30872128
Toxicol Appl Pharmacol. 2020 Dec 1;408:115255
pubmed: 33007385
Eur Respir J. 2021 Jul 29;58(1):
pubmed: 33833036
Thorax. 2017 Jul;72(7):610-619
pubmed: 28213592
J Occup Health. 2019 Jan;61(1):10-18
pubmed: 30698346
Acta Pharmacol Sin. 2022 Apr;43(4):908-918
pubmed: 34316030